This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Asymbescaline" – news · newspapers · books · scholar · JSTOR (August 2019) |
Names | |
---|---|
Preferred IUPAC name 2-(3,4-Diethoxy-5-methoxyphenyl)ethan-1-amine | |
Other names 3,4-Diethoxy-5-methoxyphenethylamine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C13H21NO3 |
Molar mass | 239.315 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
Asymbescaline (3,4-diethoxy-5-methoxyphenethylamine) is a lesser-known psychedelic drug. It is a homolog of mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 200–280 mg, and the duration listed as 10–15 hours. Asymbescaline produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of asymbescaline.
See also
External links
References
This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it. |